Generic vs Branded Drugs – A poll for Doctors
This is how the medical community has responded to a quick poll on generic vs branded questions.
PM Modi’s speech on insistence of the generics stirred a hornet’s nest. While the intentions are good, implementation will be a challenge, feel medical professionals. While it aims to minimise the doctor’s power play, in reality the power may just shift to the pharmacy counters, feel many. For pharma brands, this debate underscores the growing importance of HCP engagement strategies in India — building trust with doctors goes beyond prescriptions and requires meaningful, evidence-based communication.
To get a different POV on drugs, click here.
FAQ
What do Indian doctors prefer — generic or branded drugs?
The preference leans strongly toward branded drugs, especially those from trusted companies. Broad industry surveys show that a clear majority of doctors hesitate to recommend generics from unknown manufacturers. Even when physicians believe generic versions are high quality, their actual prescribing habits show that brand familiarity and a manufacturer’s reputation are still the main deciding factors in daily practice.
How does brand communication influence prescription decisions in India?
It plays a massive role. When doctors avoid prescribing generics from unknown companies, they are sending a clear signal. They are showing that brand trust, which comes from steady and credible communication, is what actually guides their decisions. Because of this, pharma brands that focus on real communication with doctors have a huge, lasting advantage that strict market policies cannot take away.
What does HCP research say about generic vs branded preference in India?
Industry feedback reveals a nuanced picture. While a significant proportion of doctors trust generic drug quality in principle, the majority believe that making generic-name prescriptions mandatory will not actually help patients. The real concern is not the molecule itself. It is what happens when pharmacy counters, rather than doctors, start making the final decision on which brand a patient receives.
Will making generic prescriptions mandatory reduce medicine costs for Indian patients?
Most doctors think it won’t work out that simply. Lowering costs is a great goal, but without strong quality checks and better control over pharmacies, patients won’t benefit. The power just moves from the doctor’s pen to the retail pharmacy counter. Unfortunately, that shift does not always protect the patient’s best interest or their health.
Why do Indian doctors still trust branded drugs over generics from unknown manufacturers?
For a doctor, a known brand is a guarantee of quality. Unknown manufacturers do not have a proven track record, clinical familiarity, or any relationship with the person writing the prescription. Without that basic infrastructure of trust, most doctors openly share that they are uncomfortable recommending generic medicines from companies they have never heard of.